Image may be NSFW.
Clik here to view.
Johnson & Johnson (NYSE:JNJ) today reported first-quarter sales and earnings results, topping analysts’ expectations on Wall Street.
The company’s pharmaceutical business delivered “robust growth,” chairman & CEO Alex Gorsky said in a statement; worldwide global sales grew 19.4% to $9.8 billion for the first quarter compared to same period in 2017.
Get the full story at our sister site, Drug Delivery Business News.
The post Johnson & Johnson’s global pharma sales up 19% in Q1 appeared first on MassDevice.
